The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP

類似資料

• Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration
  著者:: Katherine O. Kopp, 等
  出版事項: (2024-07-01)
• The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction
  著者:: Rizvi AA, 等
  出版事項: (2022-04-01)
• Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
  著者:: Patrick J. Knerr, 等
  出版事項: (2022-09-01)
• Physiology and clinical applications of GIP
  著者:: Shunsuke Yamane, 等
  出版事項: (2025-07-01)
• Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
  著者:: Dorte B. Zilstorff, 等
  出版事項: (2024-03-01)